[PDF][PDF] Off-label drug use in pediatric patients.

E Kimland, V Odlind - Clinical Pharmacology & Therapeutics, 2012 - researchgate.net
Until recently, it was considered unethical or impossible to perform clinical trials of new
medicines in children. As a consequence, many medicines used for treating children are …

A literature review on off-label drug use in children

C Pandolfini, M Bonati - European journal of pediatrics, 2005 - Springer
The aim was to compare results of studies performed in different settings worldwide and
identify common therapeutic areas to allow for focused interventions, because off-label drug …

Towards printed pediatric medicines in hospital pharmacies: Comparison of 2D and 3D-printed orodispersible warfarin films with conventional oral powders in unit …

H Öblom, E Sjöholm, M Rautamo, N Sandler - Pharmaceutics, 2019 - mdpi.com
To date, the lack of age-appropriate medicines for many indications results in dose
manipulation of commercially available dosage forms, commonly resulting in inaccurate …

[PDF][PDF] Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products

BD Glass, A Haywood - J Pharm Pharm Sci, 2006 - ualberta.ca
The pharmacist, both in community and hospital pharmacy practice, is often challenged with
the preparation of a liquid dosage form not available commercially for paediatric patients …

Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and …

M Cirri, N Mennini, F Maestrelli, P Mura… - International journal of …, 2017 - Elsevier
An innovative pediatric oral formulation of hydrochlorothiazide (HCT)(2 mg/mL), endowed
with improved bioavailability and sustained release properties and suitable for the …

[PDF][PDF] Unlicensed and off-label drug use in a Swiss paediatric university hospital

H Stoetter, J Cotting, M Beck-Popovic, JF Tolsa… - Swiss medical …, 2006 - smw.ch
Background: Many medicines used in newborns, infants, children and adolescents are not
licensed (“unlicensed”) or are prescribed outside the terms of the marketing authorization …

The use of unlicensed and off-label medicines in the neonate

S Conroy, J McIntyre - Seminars in Fetal and Neonatal Medicine, 2005 - Elsevier
The use of unlicensed and off-label medicines in neonates in intensive care is common and
widespread. Up to 93% of babies receive at least one unlicensed or off-label medicine …

Manipulating tablets and capsules given to hospitalised children in Norway is common practice

K Bjerknes, S Bøyum, S Kristensen… - Acta …, 2017 - Wiley Online Library
Aim This study provided an overview of manipulating oral medicines given to hospitalised
children and evaluated this practice in two hospitals. It focused on the type of manipulation …

[HTML][HTML] Cellulose and its derivatives use in the pharmaceutical compounding practice

FD Marques-Marinho… - Cellulose-medical …, 2013 - intechopen.com
For centuries, the pharmaceutical profession has provided services of fundamental value to
society, such as the procurement, storage, compounding and dispensing of drugs. In recent …

[PDF][PDF] Quality, safety and efficacy in the 'off-label'use of medicines

TE Kairuz, D Gargiulo, C Bunt, S Garg - Curr Drug Saf, 2007 - academia.edu
Suitable dosage forms are not always available for specific patient populations and must be
extemporaneously compounded. Extemporaneous preparation is the manipulation of drugs …